JPRN-UMIN000004867已完成4 期
Dialyzabikity of levofloxacin - Dialyzabikity of levofloxacin
Department of Nephrology, Tsukuba University Hospital0 个研究点目标入组 10 人开始时间: 2011年1月31日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Anemia (Hb<9mg/dl) 2) severe hepatic dysfunction (AST 3 times higher than upper normal limit of the insitution. 3)pregnant 4)allergic reaction to levofloxacin 5) history of epilepsy 6) Patients resercher regarded as not suitable
研究者
相似试验
已完成
4 期
Dialyzability of SitafloxaciChronic renal failureJPRN-UMIN000006610Department of Nephrology, Tsukuba University Hospital10
招募中
4 期
Pharmacokinetic study and safety of levofloxacin in pediatric tuberculosis treatmentMulti-drug resistant tuberculosisIsoniazid resistant tuberculosispatient with toxicity from the first line antituberculosisMDR-Hr-Toxicity from the first line anti-LevofloxacinTBTCTR20190515001Center of Excellence for Pediatric Infectious Diseases and Vaccines20
进行中（未招募）
1 期
Population pharmacokinetics of levofloxacin in intensive care patients with severe community-acquired pneumonia - Lévo-PharmMedDRA version: 14.0 Level: LLT Classification code 10032502 Term: Other specified alveolar and parietoalveolar pneumopathies System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorderscommunity-acquired pneumoniaEUCTR2011-002177-34-FRCHU de Toulouse65
已完成
2 期
Comparing the effect of levofloxacin with azithromycin in improving pulmonary function of patients with bronchiectasisIRCT20100102002954N28Shahroud University of Medical Sciences72
已完成
不适用
Comparison of efficacy and safety of levofloxacin-containing versus standard sequential therapy in eradication of Helicobacter pylori infection in KoreaHelicobacter pylori infectionJPRN-UMIN000015375Severance Hospital, Yonsei University200